Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Stroke. 2014 Nov 11;45(12):3597–3605. doi: 10.1161/STROKEAHA.114.007404

Table 1.

Demographics and clinical characteristics of 355 childhood arterial ischemic stroke cases

n (%)
Demographics
  Age in years, median (IQR) 7.6 (2.8, 14.3)
  Male gender 199 (56.1)
  Race
    White 230 (64.8)
    Black 39 (11.0)
    Indian/South Asian 26 (7.3)
    East Asian 9 (2.5)
    First Nations/Aboriginal 4 (1.1)
    Middle Eastern 3 (0.8)
    Pacific Islander 1 (0.3)
    Mixed or other 38 (10.7)
    Unknown 5 (1.4)
  Ethnicity
    Non-Hispanic 289 (81.4)
    Hispanic 47 (13.2)
    Mixed or other 19 (5.4)
  Country
    USA 223 (62.8)
    Canada 60 (16.9)
    Australia 16 (4.5)
    Philippines 16 (4.5)
    Chile 14 (3.9)
    United Kingdom 11 (3.1)
    France 6 (1.7)
    Serbia 5 (1.4)
    China 4 (1.1)
Stroke presentation
  Focal signs
    Hemiparesis 285 (80.3)
    Dysarthria 97 (27.3)
    Aphasia 79 (22.3)
    Ataxia 71 (20.0)
    Visual field deficit 46 (13.0)
  Non-focal signs
    Headache 126 (35.5)
    Decreased level of consciousness 102 (28.7)
    Nausea/vomiting 85 (23.9)
    Seizures at presentation 84 (23.7)
    Vertigo 40 (11.3)
    Diplopia 12 (3.4)
    Papilledema 4 (1.1)
Risk factors or co-morbidities (not mutually exclusive)
  Cardiac disease 107 (30.1)
    Congenital heart disease 64 (18.0)
    Acquired heart disease 21 (5.9)
    Isolated patent foramen ovale 21 (5.9)
    Stroke at cardiac surgery (<72 hours) 10 (2.8)
    Other cardiac disease 41 (11.5)
  Other chronic disorders
    Sickle cell anemia 13 (3.7)
    Downs syndrome 11 (3.1)
    Other genetic syndrome 16 (4.5)
    Migraine 12 (3.4)
    Prothrombotic state 10 (2.8)
    Oral contraceptives (females only) 10 (6.4)
    Indwelling catheter 9 (2.5)
    Iron deficiency anemia 6 (1.7)
    Brain tumor 5 (1.4)
      Benign 2 (0.6)
      Malignant 3 (0.8)
    Aneurysm 3 (0.8)
    PHACES syndrome/hemangioma 3 (0.8)
    Hematologic malignancy 2 (0.6)
    L-asparaginase therapy 2 (0.6)
    Connective tissue disease 2 (0.6)
    Ventriculoperitoneal shunt 1 (0.3)
  Acute systemic illness
    Fever lasting >48 hours 44 (12.4)
    Systemic sepsis or bacteremia 20 (5.6)
    Dehydration 18 (5.1)
    Shock 9 (2.5)
    Viral gastroenteritis 2 (0.6)